KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Total Current Liabilities: 2010-2025

Historic Total Current Liabilities for TherapeuticsMD (TXMD) over the last 11 years, with Sep 2025 value amounting to $4.9 million.

  • TherapeuticsMD's Total Current Liabilities fell 17.25% to $4.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.9 million, marking a year-over-year decrease of 17.25%. This contributed to the annual value of $5.2 million for FY2024, which is 24.63% down from last year.
  • Per TherapeuticsMD's latest filing, its Total Current Liabilities stood at $4.9 million for Q3 2025, which was up 6.07% from $4.7 million recorded in Q2 2025.
  • In the past 5 years, TherapeuticsMD's Total Current Liabilities registered a high of $264.8 million during Q1 2022, and its lowest value of $4.7 million during Q2 2025.
  • For the 3-year period, TherapeuticsMD's Total Current Liabilities averaged around $8.4 million, with its median value being $6.0 million (2024).
  • In the last 5 years, TherapeuticsMD's Total Current Liabilities surged by 332.14% in 2022 and then crashed by 92.70% in 2023.
  • Over the past 5 years, TherapeuticsMD's Total Current Liabilities (Quarterly) stood at $252.9 million in 2021, then slumped by 81.48% to $46.8 million in 2022, then tumbled by 85.37% to $6.9 million in 2023, then fell by 24.63% to $5.2 million in 2024, then dropped by 17.25% to $4.9 million in 2025.
  • Its Total Current Liabilities was $4.9 million in Q3 2025, compared to $4.7 million in Q2 2025 and $4.7 million in Q1 2025.